APA (7th ed.) Citation

P, G., ME, O., A, G., L, P. A., F, L., JM, R., & J, P. (2017). Treating KRAS-mutant NSCLC: Latest evidence and clinical consequences. Therapeutic advances in medical oncology, 9(9), 589. https://doi.org/10.1177/1758834017719829

Chicago Style (17th ed.) Citation

P, Garrido, Olmedo ME, Gómez A, Paz Ares L, López-Ríos F, Rosa-Rosa JM, and Palacios J. "Treating KRAS-mutant NSCLC: Latest Evidence and Clinical Consequences." Therapeutic Advances in Medical Oncology 9, no. 9 (2017): 589. https://doi.org/10.1177/1758834017719829.

MLA (9th ed.) Citation

P, Garrido, et al. "Treating KRAS-mutant NSCLC: Latest Evidence and Clinical Consequences." Therapeutic Advances in Medical Oncology, vol. 9, no. 9, 2017, p. 589, https://doi.org/10.1177/1758834017719829.